Annual FCF
-$123.29 M
+$15.80 M+11.36%
December 31, 2023
Summary
- As of February 7, 2025, RNA annual free cash flow is -$123.29 million, with the most recent change of +$15.80 million (+11.36%) on December 31, 2023.
- During the last 3 years, RNA annual FCF has fallen by -$85.08 million (-222.68%).
- RNA annual FCF is now -5567.49% below its all-time high of $2.25 million, reached on December 31, 2019.
Performance
RNA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$67.32 M
-$1.78 M-2.72%
September 1, 2024
Summary
- As of February 7, 2025, RNA quarterly free cash flow is -$67.32 million, with the most recent change of -$1.78 million (-2.72%) on September 1, 2024.
- Over the past year, RNA quarterly FCF has dropped by -$29.61 million (-78.50%).
- RNA quarterly FCF is now -530.48% below its all-time high of $15.64 million, reached on December 31, 2023.
Performance
RNA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$188.51 M
-$29.61 M-18.63%
September 1, 2024
Summary
- As of February 7, 2025, RNA TTM free cash flow is -$188.51 million, with the most recent change of -$29.61 million (-18.63%) on September 1, 2024.
- Over the past year, RNA TTM FCF has dropped by -$9.54 million (-5.33%).
- RNA TTM FCF is now -1521.22% below its all-time high of $13.26 million, reached on June 30, 2019.
Performance
RNA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RNA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.4% | -78.5% | -5.3% |
| 3 y3 years | -222.7% | -211.9% | -124.6% |
| 5 y5 years | -1170.5% | -1041.2% | -8459.7% |
RNA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.1% | +11.4% | -530.5% | +5.6% | -91.3% | at low |
| 5 y | 5-year | -5567.5% | +11.4% | -530.5% | +5.6% | -8459.7% | at low |
| alltime | all time | -5567.5% | +11.4% | -530.5% | +5.6% | -1521.2% | at low |
Avidity Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$67.32 M(+2.7%) | -$188.51 M(+18.6%) |
| Jun 2024 | - | -$65.53 M(-8.1%) | -$158.91 M(+10.5%) |
| Mar 2024 | - | -$71.30 M(-555.9%) | -$143.80 M(+16.6%) |
| Dec 2023 | -$123.29 M(-11.4%) | $15.64 M(-141.5%) | -$123.29 M(-31.1%) |
| Sep 2023 | - | -$37.71 M(-25.2%) | -$178.97 M(+3.4%) |
| Jun 2023 | - | -$50.43 M(-0.7%) | -$173.11 M(+8.5%) |
| Mar 2023 | - | -$50.79 M(+26.8%) | -$159.55 M(+14.7%) |
| Dec 2022 | -$139.09 M(+41.1%) | -$40.04 M(+25.7%) | -$139.09 M(+9.5%) |
| Sep 2022 | - | -$31.85 M(-13.6%) | -$126.97 M(+8.8%) |
| Jun 2022 | - | -$36.87 M(+21.5%) | -$116.70 M(+7.4%) |
| Mar 2022 | - | -$30.33 M(+8.6%) | -$108.68 M(+10.3%) |
| Dec 2021 | -$98.55 M | -$27.92 M(+29.4%) | -$98.55 M(+17.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$21.58 M(-25.2%) | -$83.94 M(+16.1%) |
| Jun 2021 | - | -$28.84 M(+42.7%) | -$72.32 M(+41.1%) |
| Mar 2021 | - | -$20.21 M(+51.8%) | -$51.27 M(+34.2%) |
| Dec 2020 | -$38.21 M(-1794.4%) | -$13.31 M(+33.7%) | -$38.21 M(+27.3%) |
| Sep 2020 | - | -$9.96 M(+27.8%) | -$30.01 M(+15.6%) |
| Jun 2020 | - | -$7.79 M(+9.0%) | -$25.95 M(+823.8%) |
| Mar 2020 | - | -$7.15 M(+39.9%) | -$2.81 M(-224.6%) |
| Dec 2019 | $2.25 M(-123.2%) | -$5.11 M(-13.4%) | $2.25 M(-69.4%) |
| Sep 2019 | - | -$5.90 M(-138.4%) | $7.37 M(-44.5%) |
| Jun 2019 | - | $15.35 M(-835.9%) | $13.26 M(-735.9%) |
| Mar 2019 | - | -$2.09 M | -$2.09 M |
| Dec 2018 | -$9.70 M | - | - |
FAQ
- What is Avidity Biosciences annual free cash flow?
- What is the all time high annual FCF for Avidity Biosciences?
- What is Avidity Biosciences annual FCF year-on-year change?
- What is Avidity Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Avidity Biosciences?
- What is Avidity Biosciences quarterly FCF year-on-year change?
- What is Avidity Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Avidity Biosciences?
- What is Avidity Biosciences TTM FCF year-on-year change?
What is Avidity Biosciences annual free cash flow?
The current annual FCF of RNA is -$123.29 M
What is the all time high annual FCF for Avidity Biosciences?
Avidity Biosciences all-time high annual free cash flow is $2.25 M
What is Avidity Biosciences annual FCF year-on-year change?
Over the past year, RNA annual free cash flow has changed by +$15.80 M (+11.36%)
What is Avidity Biosciences quarterly free cash flow?
The current quarterly FCF of RNA is -$67.32 M
What is the all time high quarterly FCF for Avidity Biosciences?
Avidity Biosciences all-time high quarterly free cash flow is $15.64 M
What is Avidity Biosciences quarterly FCF year-on-year change?
Over the past year, RNA quarterly free cash flow has changed by -$29.61 M (-78.50%)
What is Avidity Biosciences TTM free cash flow?
The current TTM FCF of RNA is -$188.51 M
What is the all time high TTM FCF for Avidity Biosciences?
Avidity Biosciences all-time high TTM free cash flow is $13.26 M
What is Avidity Biosciences TTM FCF year-on-year change?
Over the past year, RNA TTM free cash flow has changed by -$9.54 M (-5.33%)